2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
74
Prostatic Neoplasms
54
Breast Neoplasms
15
Neoplasms
11
Sarcoma
10
Endometrial Neoplasms
10
Vaginal Neoplasms
8
Esophageal Neoplasms
6
Uterine Neoplasms
5
Radiation Injuries
5
Lung Neoplasms
5
Liver Neoplasms
5
Vulvar Neoplasms
4
Glioblastoma
4
Carcinoma, Ductal, Breast
4
Adenocarcinoma
4
Retinoblastoma
3
Ovarian Neoplasms
3
Neuroectodermal Tumors, Primitive, Peripheral
3
Hyperthermia
3
Gliosarcoma
3
Desmoplastic Small Round Cell Tumor
3
Central Nervous System Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Carcinoma, Hepatocellular
3
Breast Carcinoma In Situ
3
Brain Neoplasms
3
Uveal Melanoma
2
Rhabdomyosarcoma
2
Rectal Neoplasms
2
Interventions
Carboplatin
5
Paclitaxel
4
pembrolizumab
3
Educational Status
3
niraparib
2
anlotinib
2
Therapeutic Touch
2
Surveys and Questionnaires
2
Standard of Care
2
Radiotherapy
2
Pemetrexed
2
Palliative Care
2
Nivolumab
2
Methods
2
Interviews as Topic
2
Gemcitabine
2
Early Intervention, Educational
2
Bevacizumab
2
temsirolimus
1
rucaparib
1
relacorilant
1
olaparib
1
nintedanib
1
nilotinib
1
liposomal doxorubicin
1
lenvatinib
1
fosaprepitant
1
atezolizumab
1
argatroban
1
Watchful Waiting
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genital Neoplasms, Female
×
Brachytherapy
×
Clear all
NCT05242861
2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
300 enrolled